CN103429257A - 用于预防宿醉症状的含有二胺氧化酶的组合物 - Google Patents

用于预防宿醉症状的含有二胺氧化酶的组合物 Download PDF

Info

Publication number
CN103429257A
CN103429257A CN2012800138171A CN201280013817A CN103429257A CN 103429257 A CN103429257 A CN 103429257A CN 2012800138171 A CN2012800138171 A CN 2012800138171A CN 201280013817 A CN201280013817 A CN 201280013817A CN 103429257 A CN103429257 A CN 103429257A
Authority
CN
China
Prior art keywords
dao
compositions
histamine
night
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012800138171A
Other languages
English (en)
Chinese (zh)
Inventor
C·德鲁里乌
J·J·德鲁里乌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Healthcare Espana SL
Original Assignee
Dr Healthcare Espana SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45922735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN103429257(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dr Healthcare Espana SL filed Critical Dr Healthcare Espana SL
Publication of CN103429257A publication Critical patent/CN103429257A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C12Y104/03006—Amine oxidase (copper-containing)(1.4.3.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C12Y104/03022—Diamine oxidase (1.4.3.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN2012800138171A 2011-03-18 2012-03-16 用于预防宿醉症状的含有二胺氧化酶的组合物 Pending CN103429257A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES201130380A ES2388515B1 (es) 2011-03-18 2011-03-18 Uso de la diaminooxidasa para la prevención de los síntomas de la resaca.
ESP201130380 2011-03-18
PCT/IB2012/051275 WO2012127391A1 (en) 2011-03-18 2012-03-16 Composition comprising diamine oxidase for the prevention of hangover symptoms

Publications (1)

Publication Number Publication Date
CN103429257A true CN103429257A (zh) 2013-12-04

Family

ID=45922735

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012800138171A Pending CN103429257A (zh) 2011-03-18 2012-03-16 用于预防宿醉症状的含有二胺氧化酶的组合物

Country Status (13)

Country Link
US (1) US20130344136A1 (es)
EP (1) EP2686006B2 (es)
CN (1) CN103429257A (es)
BR (1) BR112013023710A2 (es)
CO (1) CO6801745A2 (es)
DK (1) DK2686006T4 (es)
ES (2) ES2388515B1 (es)
HU (1) HUE033445T2 (es)
MX (1) MX346159B (es)
PL (1) PL2686006T5 (es)
PT (1) PT2686006T (es)
RU (1) RU2627128C2 (es)
WO (1) WO2012127391A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2426539B1 (es) 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
EP2956269B1 (en) 2013-02-15 2021-10-13 Matthew Fagan Method and system of processing of a long product

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1980689A (zh) * 2004-07-07 2007-06-13 阿尔贝特·米斯比希勒 含二氨基氧化酶的药物组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8319540D0 (en) 1983-07-20 1983-08-24 Bovril Ltd Amine removal
GB8325627D0 (en) 1983-09-24 1983-10-26 Scras Therapeutic compositions
US4725540A (en) 1984-07-09 1988-02-16 Emil Underberg Process for the preparation of amine-oxidase containing material, so produced amine-oxidase containing material
DE19502789A1 (de) 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
RU2143211C1 (ru) * 1999-04-08 1999-12-27 Общество с ограниченной ответственностью "Производственно-торговое предприятие "Медтехника" Биологически активная пищевая добавка для алкогольных напитков
IT1317067B1 (it) * 2000-11-29 2003-05-26 Univ Roma Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico.
US7063865B2 (en) * 2002-05-10 2006-06-20 Jeremy Park Jones Composition and method for substantially reducing the deleterious effects of alcohol on the body
CA2623304C (en) * 2005-09-22 2014-07-29 Snow Brand Milk Products Co., Ltd. Medicine, food and drink or feed containing sphingomyelin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1980689A (zh) * 2004-07-07 2007-06-13 阿尔贝特·米斯比希勒 含二氨基氧化酶的药物组合物

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
LAURA MAINTZ等: "Histamine and histamine intolerance", 《AM J CLIN NUTR》, vol. 85, 31 December 2007 (2007-12-31), pages 1185 *
ROBERT SWIFT等: "Alcohol Hangover Mechanisms and Mediators", 《ALCOHOL HEALTH & RESEARCH WORLD》, vol. 22, no. 1, 31 December 1998 (1998-12-31), pages 54 - 60 *
天生: "提防宿醉症", 《环境》, 15 August 1996 (1996-08-15), pages 21 *
张建华: "缓解宿醉有妙招", 《医药保健杂志》, 1 July 2006 (2006-07-01), pages 12 - 13 *

Also Published As

Publication number Publication date
EP2686006B2 (en) 2020-02-19
ES2388515B1 (es) 2013-10-01
MX346159B (es) 2017-03-09
PL2686006T5 (pl) 2020-07-13
DK2686006T3 (en) 2017-03-13
ES2388515A1 (es) 2012-10-16
RU2627128C2 (ru) 2017-08-03
MX2013010694A (es) 2013-10-03
EP2686006A1 (en) 2014-01-22
ES2618930T3 (es) 2017-06-22
CO6801745A2 (es) 2013-11-29
US20130344136A1 (en) 2013-12-26
HUE033445T2 (en) 2017-11-28
PT2686006T (pt) 2017-03-20
PL2686006T3 (pl) 2017-07-31
BR112013023710A2 (pt) 2016-12-13
RU2013144967A (ru) 2015-04-27
ES2618930T5 (es) 2020-11-04
WO2012127391A1 (en) 2012-09-27
DK2686006T4 (da) 2020-05-18
EP2686006B1 (en) 2016-12-14

Similar Documents

Publication Publication Date Title
Wöhrl et al. Histamine intolerance-like symptoms in healthy volunteers after oral provocation with liquid histamine.
CN106236739B (zh) 含有叶黄素/叶黄素酯的组合物及其应用
CN101977600A (zh) 原人参二醇-型人参皂甙组合物及其用途
CN101012419A (zh) 透明质酸在酒类中的应用及含透明质酸的啤酒
KR102107387B1 (ko) 흑삼 추출물을 함유하는 숙취해소용 음료 조성물
US20100316735A1 (en) Compositions and methods for reducing hangover symptoms
CN103142655B (zh) 用于治疗痛风的复合益生菌及其制备方法
US20020155103A1 (en) Activated charcoal based composition and method for reducing hangover symptomps associated with the consumption of alcohol containing beverages
CN104853779A (zh) 包含环糊精的儿茶素生物利用度增强剂
CN107198246A (zh) 一种保健组合物与一种保健制剂
CN107836719A (zh) 一种解酒醒酒益生元组合物
CN103429257A (zh) 用于预防宿醉症状的含有二胺氧化酶的组合物
US20060263385A1 (en) Composition to relieve side effects of alcohol intoxication
CN101845384A (zh) 一种保健酒
CA2914436A1 (en) Enzyme formulation for use as food supplement
CN107787191A (zh) 包含饮料和珠粒的用于减重的组合物
JP2002265365A (ja) 好中球機能抑制剤
CN102640893B (zh) 一种黑麦芽全草复合营养剂及其制备方法
JP2007008866A (ja) 血圧降下剤組成物
CN105999246A (zh) 一种水蛭素和干水蛭药酒及制备方法与应用
RU2732244C2 (ru) Композиции для лечения кандидозных инфекций
CN108720013A (zh) 一组由果糖和茶叶提取物组成的醒酒护肝的保健食品的配方及生产工艺
KR20040097813A (ko) 식욕억제, 체지방 감소 및 배변 활성화등 3가지 기능을 갖는 항비만 기능성 조성물
CN109045286A (zh) 一种减小饮酒反应、降低酒精肝损伤的组合物及应用
JPS61134313A (ja) アルデヒドの毒性抑制剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1192142

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20131204

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1192142

Country of ref document: HK